NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 175 filers reported holding NEVRO CORP in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $793 | +62.8% | 31,209 | +131.6% | 0.08% | +64.6% |
| Q1 2023 | $487 | -62.5% | 13,477 | -58.9% | 0.05% | -70.2% |
| Q4 2022 | $1,299 | -99.5% | 32,803 | +429.2% | 0.16% | +292.7% |
| Q2 2022 | $272,000 | -35.2% | 6,199 | +155.5% | 0.04% | -40.6% |
| Q4 2020 | $420,000 | +33.3% | 2,426 | -9.6% | 0.07% | +86.5% |
| Q4 2019 | $315,000 | – | 2,684 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |